Company Profile
Nemaura Medical Stock Price, News & Catalysts
- Ticker:
- NMRD
- Exchange:
- PINK
- Sector:
- Biopharma
- Location:
- United Kingdom and trades in the U
Stock performance
0.00 USD (0.00%)
Close
Last updated: October 1, 2026
—
Market cap
Why the stock is moving
As of Oct 1, 2026, NMRD was little changed and closed at $0.0001. No new same-company headline was identified in the current news window.
Company overview
Non-Invasive Glucose Monitoring Company
Nemaura Medical develops wearable systems intended to measure glucose without penetrating the skin. Its platform is designed for metabolic health, diabetes management, and behavior-change programs.
SugarBEAT Sensor Platform
SugarBEAT uses a small skin-worn sensor and transmitter to collect glucose readings from interstitial fluid. Data are displayed through a mobile application to show glucose patterns and trends throughout the day.
proBEAT Metabolic Program
proBEAT combines glucose data with coaching and digital tools for people with type 2 diabetes or elevated metabolic risk. The service is intended to help users understand how food, activity, and lifestyle affect glucose response.
Device and Subscription Economics
Potential revenue sources include reusable transmitters, disposable sensors, software, coaching subscriptions, and partnerships with healthcare or wellness organizations. Regulatory clearance and reimbursement are important to broader clinical adoption.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Nemaura Medical (NMRD)?
Nemaura Medical (NMRD) most recently closed at 0.00 USD, a 0.00% move versus the previous session.
What does Nemaura Medical do?
Non-Invasive Glucose Monitoring Company Nemaura Medical develops wearable systems intended to measure glucose without penetrating the skin. Its platform is designed for metabolic health, diabetes management, and behavior-change programs. SugarBEAT Sensor Platform SugarBEAT uses a small skin-worn sensor and transmitter to collect glucose readings from...
On which exchange is NMRD stock listed?
Nemaura Medical (NMRD) is associated with PINK, United Kingdom and trades in the U, Biopharma.
What is Non-Invasive?
Non-Invasive Glucose Monitoring Company Nemaura Medical develops wearable systems intended to measure glucose without penetrating the skin.
Which conditions is Nemaura Medical targeting with Non-Invasive?
Nemaura Medical is associated with metabolic disease, diabetes based on its company overview and current catalyst commentary.
What is Glucose?
Non-Invasive Glucose Monitoring Company Nemaura Medical develops wearable systems intended to measure glucose without penetrating the skin.
What is Monitoring?
Non-Invasive Glucose Monitoring Company Nemaura Medical develops wearable systems intended to measure glucose without penetrating the skin.